About Partisan Management Group
Partisan Management Group is a venture capital firm founded in 1999. It is primarily based out of Boulder, United States. As of Oct 2022, Partisan Management Group has invested in 15 companies. It primarily invests in Seed round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Consumer and HealthTech. Most recently it participated in the $***** Seed round of Switch Therapeutics Overall, Partisan Management Group portfolio has seen 1 IPO and 4 acquisitions including key companies like TriSalus Life Sciences, ZS Pharma and Medivance. A lot of funds co-invest with Partisan Management Group, with names like High Country Ventures sharing a substantial percentage of its portfolio. Partisan Management Group has team of 1 people.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 1 more
Portfolio IPOs
Portfolio Soonicorns
Partisan Management Group's List of Top Investments
Partisan Management Group has a portfolio of 15 companies. Their most notable investments are in Preceptis Medical and ZS Pharma.Their portfolio spans across United States and Ireland. They have invested in Life Sciences, Consumer, HealthTech and 2 other sectors, across stages such as Seed, Series A and 1 more. Here is the list of top investments by Partisan Management Group:TriSalus Life Sciences is involved in developing drug delivery devices to treat cancers. They have developed a technology platform, Pressure-Enabled Drug Delivery (PEDD), which is designed to improve the distribution and penetration of therapy in solid tumors.
Key facts about TriSalus Life Sciences
- Founded Year: 2009
- Location: Westminster (United States)
- Annual Revenue: $10M - $50M as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $83.4M
- Employee Count: 133 as on Aug 31, 2026
- Investors: Nantahala Capital Management, Tullis Health Investors and 7 Others
- Latest Funding Round: Post IPO, Apr 30, 2025, $*****
- Highlight: Public
2. Neuronetics
Transforming neurohealth with innovative, non-drug TMS therapy for mental health. The company is dedicated to improving the lives of individuals suffering from psychiatric disorders by offering patient-centric medical devices. They specialize in transcranial magnetic stimulation (TMS) treatment, providing a non-drug, non-invasive alternative for those with depression and OCD. Committed to practice success, they offer ongoing support and strive to expand their capabilities to cover additional indications. Their approach focuses on compassion, innovation, and growth, aiming to provide a safe, effective, and durable treatment option. They are committed to compliance and ethical practices, ensuring the highest quality of care for both patients and healthcare providers.
Key facts about Neuronetics
- Founded Year: 2001
- Location: Malvern (United States)
- Annual Revenue: $100M - $500M as on Dec 31, 2025
- Valuation: $*****
- Stage: Series G
- Total Funding till date: $178M
- Employee Count: 216 as on Mar 31, 2026
- Investors: Western Technology Investment, Quaker Partners Management and 16 Others
- Latest Funding Round: Series G, Jun 06, 2017, $*****
Provider of a wearable drug delivery solution. The company's drug delivery device include enFuse for injectable therapies which enables a range of flexible delivery options for patients and healthcare providers, including a range of viscosities, volumes, delivery times, and sites for administration.
Key facts about Enable Injections
4. Team Liquid
Online eSports organization platform. The company has developed an online platform that enables eSports gaming community to play esports games, makes collective teams, communicate, and more. The platform also provides news and has stores and quests for fans.
Key facts about Team Liquid
- Founded Year: 2000
- Location: Santa Monica (United States)
- Valuation: $*****
- Stage: Series B
- Total Funding till date: $80M
- Employee Count: 409 as on Aug 31, 2026
- Investors: Tullis Health Investors, Partisan Management Group and 11 Others
- Latest Funding Round: Series B, May 05, 2022, $*****
- Highlight: Editors' Pick
Developer of therapeutics for neurological disorders. It offers CASi (Conditionally Activated siRNA) molecules that activate only in selective cells and allow for expansion into targets by precision RNAi approaches to treat the central nervous system and systemic indications.
Key facts about Switch Therapeutics
- Founded Year: 2020
- Location: San Francisco (United States)
- Stage: Series A
- Total Funding till date: $71.9M
- Employee Count: 28 as on Aug 31, 2026
- Investors: Tullis Health Investors, Lilly and 13 Others
- Latest Funding Round: Series A, Mar 14, 2023, $*****
- Highlight: Editors' Pick
Partisan Management Group's Year-on-Year Investment Trends
Partisan Management Group has invested in 15 companies over the last 25 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in Switch Therapeutics and most recent follow-on round was in TriSalus Life Sciences.Partisan Management Group's Investments by Stage
Partisan Management Group has made 3 investments in Seed stage with an average round size of $10.3M, 3 investments in Series A stage with an average round size of $11.3M and 1 investment in Series B stage with an average round size of $16M.Stage of entry | No. of Investments |
|---|---|
Seed | 3 |
Series A | 3 |
Series B | 1 |
Note: We have considered here, only first round of investments
Partisan Management Group's Investments by Sector
Partisan Management Group has a diverse portfolio, with companies operating in the Life Sciences, Consumer and Gaming. Notably, it has invested in 11 Enterprise (B2B) companies, 11 Tech companies, 3 Consumer (B2C) companies and at least 3 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 6 |
Consumer | 1 |
Gaming | 1 |
Note: We have considered here, only first round of investments
Partisan Management Group's Investments by Geography
Partisan Management Group has made most investments in United States (7).Partisan Management Group's recent investments
Partisan Management Group has not made any investment in 2026 so far.Here are the most recent investments by Partisan Management Group:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Oct 04, 2022 | United States | Seed | 2629 | ||
Jun 01, 2017 | United States | Series A | 5429 | ||
Nov 05, 2015 | United States | Series C | 9875 | ||
Jan 31, 2014 | United States | Series A | 1697 | - | |
Nov 07, 2013 | United States | Series B | 7675 | [+1] |
IPOs and Publicly Listed companies in Partisan Management Group's Portfolio
1 of Partisan Management Group's portfolio company became public - TriSalus Life Sciences. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Mar 2021.Here are Partisan Management Group's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 19, 2021 | Jul 06, 2011 | Series A | 2788 |
Acquired companies in Partisan Management Group's Portfolio
4 companies from Partisan Management Group's portfolio have been acquired. The most recent acquisition was ZS Pharma in Nov 2015 by AstraZeneca for $*****.Here are Partisan Management Group's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Nov 06, 2015 | Dec 20, 2010 | Seed | 4122 | |
Oct 25, 2011 | Jun 18, 2001 | Series B | 1280 | |
Sep 15, 2011 | - | - | 4698 | |
Nov 29, 2007 | - | - | 1059 |
Team profile of Partisan Management Group
Partisan Management Group has a team of 1 member located in United States. Partisan Management Group's team does not sit on the board of any company as of now.Co-investors of Partisan Management Group
Over the past 25 years, 57 investors have co-invested in Partisan Management Group's portfolio companies. This includes funds and angels.
- Invested before Partisan Management Group: Texas Emerging Technology Fund has invested before Partisan Management Group.
- Top Co-investors of Partisan Management Group: 8 investors entered a company along with Partisan Management Group. These include investors like High Country Ventures (3 companies).
- Invested after Partisan Management Group: A total of 48 investors have invested in Partisan Management Group's portfolio after their investments. Top Investors include MCG Capital (1 company), Tullis Health Investors (1 company) and KMG Capital Partners (1 company).
Recent News related to Partisan Management Group
•
Surefire Medical Closes $15M Series C Financing |FinSMEsFinSMEs•Dec 02, 2015•TriSalus Life Sciences, Tullis Health Investors, KMG Capital Partners, Partisan Management Group and 1 other
•
Surefire Medical Closes $15M Series C Financing - Surefire Medical, Inc.Surefire Medical•Dec 02, 2015•TriSalus Life Sciences, Tullis Health Investors, KMG Capital Partners, Partisan Management Group and 1 other
•
Surefire Medical Closes $15M Series C Financing for direct-to-tumor delivery systems - MedCity NewsMedCity News•Dec 02, 2015•TriSalus Life Sciences, Tullis Health Investors, KMG Capital Partners, Partisan Management Group and 1 other
•
Neuronetics Completes $34M Series F FinancingFinSMEs•Apr 27, 2015•Neuronetics, GE Ventures, Partisan Management Group, Accuitive Medical Ventures
•
Surefire Medical Completes $18.2M Series B Funding |FinSMEsFinSMEs•Nov 07, 2013•TriSalus Life Sciences, MCG Capital, Partisan Management Group, High Country Ventures
•
Surefire Medical Closes Series B Funding at $18.2 Million | Business WireBusiness Wire•Nov 07, 2013•TriSalus Life Sciences, MCG Capital, Partisan Management Group, High Country Ventures
•
Surefire Medical Closes Series B Funding at $18.2 Million - Surefire Medical, Inc.Surefire Medical•Nov 06, 2013•TriSalus Life Sciences, MCG Capital, Partisan Management Group, High Country Ventures
•
Surefire Medical Announces Closing of $6.1M Series A Financing - Surefire Medical, Inc.Surefire Medical•Jul 06, 2011•TriSalus Life Sciences, Partisan Management Group, High Country Ventures
•
Medivance Raises Series D - PE HubPE Hub•Jul 27, 2007•Medivance, Camden Partners, Skyline Ventures, Partisan Management Group and 1 other
•
Medivance(R) Completes $23 Million Private FinancingPR Newswire•Jul 26, 2007•Medivance, Camden Partners, Skyline Ventures, Partisan Management Group and 1 other
